Offering new hope for back pain sufferers, Dr. Roger Härtl and the multidisciplinary spine team at the Weill Cornell Brain and Spine Center are now recruiting patients for a new clinical trial. The trial will test an investigational medication intended to treat low back pain and disability caused by spinal disc disease.
The injectable medication, named NuQu, is made of cartilage cells and is delivered during a short, one-time treatment. Trial participants will go home within an hour...
